Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Urology
Published in: BMC Urology 1/2017

Open Access 01-12-2017 | Research article

Qualitative insights into how men with low-risk prostate cancer choosing active surveillance negotiate stress and uncertainty

Authors: Emily M. Mader, Hsin H. Li, Kathleen D. Lyons, Christopher P. Morley, Margaret K. Formica, Scott D. Perrapato, Brian H. Irwin, John D. Seigne, Elias S. Hyams, Terry Mosher, Mark T. Hegel, Telisa M. Stewart

Published in: BMC Urology | Issue 1/2017

Login to get access

Abstract

Background

Active surveillance is a management strategy for men diagnosed with early-stage, low-risk prostate cancer in which their cancer is monitored and treatment is delayed. This study investigated the primary coping mechanisms for men following the active surveillance treatment plan, with a specific focus on how these men interact with their social network as they negotiate the stress and uncertainty of their diagnosis and treatment approach.

Methods

Thematic analysis of semi-structured interviews at two academic institutions located in the northeastern US. Participants include 15 men diagnosed with low-risk prostate cancer following active surveillance.

Results

The decision to follow active surveillance reflects the desire to avoid potentially life-altering side effects associated with active treatment options. Men on active surveillance cope with their prostate cancer diagnosis by both maintaining a sense of control over their daily lives, as well as relying on the support provided them by their social networks and the medical community. Social networks support men on active surveillance by encouraging lifestyle changes and serving as a resource to discuss and ease cancer-related stress.

Conclusions

Support systems for men with low-risk prostate cancer do not always interface directly with the medical community. Spousal and social support play important roles in helping men understand and accept their prostate cancer diagnosis and chosen care plan. It may be beneficial to highlight the role of social support in interventions targeting the psychosocial health of men on active surveillance.
Literature
1.
Filson C, Marks L, Litwin M. Expectant management for men with early stage prostate cancer. CA Cancer J Clin. 2015;65:264–82.CrossRef
2.
Mohler JL, Kantoff PW, Armstrong AJ, Bahnson RR, Cohen M, D’Amico AV, et al. Prostate cancer, version 2.2014. J Natl Compr Canc Netw. 2014;12:686–718.CrossRefPubMed
3.
Thompson I, Thrasher JB, Aus G, Burnett AL, Canby-Hagino ED, Cookson MS, et al. Prostate cancer: guideline for the management of clinically localized prostate cancer 2007 update. J Urol. 2007;177(6):2106–31.CrossRefPubMed
4.
Hayes JH, Ollendorf DA, Pearson SD, Barry MJ, Kantoff PW, Stewart ST, et al. Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis. JAMA. 2010;304:2373–80.CrossRefPubMedPubMedCentral
5.
6.
Bellardita L, Rancati T, Alvisi MF, Villani D, Magnani T, Marenghi C, et al. Predictors of health-related quality of life and adjustment to prostate cancer during active surveillance. Eur Urol. 2013;64:30–6.CrossRefPubMed
7.
Kazer MW, Psutka SP, Latini DM, Bailey DE. Psychosocial aspects of active surveillance. Curr Opin Urol. 2013;23:273–7.PubMed
8.
Parker PA, Davis JW, Latini DM, Baum G, Wang X, Ward JF, et al. Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillance. BJU Int. 2016;117(3):469–77.CrossRefPubMed
9.
10.
Leventhal H, Diefenbach M, Leventhal EA. Illness cognition: using common sense to understand treatment adherence and affect cognition interactions. Cogn Ther Res. 1992;16:143–63.CrossRef
11.
Leventhal H. Findings and theory in the study of fear communications. Adv Exp Soc Psychol. 1970;5:119–86.CrossRef
12.
13.
Meadows LM, Verdi AJ, Crabtree BF. Keeping up appearances: using qualitative research to enhance knowledge of dental practice. J Dent Educ. 2003;67:981–90.PubMed
14.
Borkan J. Immersion/Crystallization. In: Crabtree BF, Miller WL, editors. Doing Qual. Res. 2nd ed. Thousand Oaks: SAGE Publications; 1999. p. 179–94.
15.
16.
17.
Gorin MA, Soloway CT, Eldefrawy A, Soloway MS. Factors that influence patient enrollment in active surveillance for low-risk prostate cancer. Urology. 2011;77:588–91.CrossRefPubMed
18.
van den Bergh RCN, van Vugt HA, Korfage IJ, Steyerberg EW, Roobol MJ, Schröder FH, et al. Disease insight and treatment perception of men on active surveillance for early prostate cancer. BJU Int. 2010;105:322–8.CrossRefPubMed
19.
Volk RJ, McFall SL, Cantor SB, Byrd TL, Le Y-CL, Kuban DA, et al. “It’s not like you just had a heart attack”: decision-making about active surveillance by men with localized prostate cancer. Psychooncology. 2014;23:467–72.CrossRefPubMed
20.
Davison BJ, Oliffe JL, Pickles T, Mroz L. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer. Oncol Nurs Forum. 2009;36:89–96.CrossRefPubMed
21.
Oliffe JL, Davison BJ, Pickles T, Mroz L. The self-management of uncertainty among men undertaking active surveillance for low-risk prostate cancer. Qual Health Res. 2009;19:432–43.CrossRefPubMed
22.
Simpson P. Does active surveillance lead to anxiety and stress? Br J Nurs. 2014;23 Suppl 1:S4–12.CrossRefPubMed
23.
Chapple A, Ziebland S, Herxheimer A, McPherson A, Shepperd S, Miller R. Is “watchful waiting” a real choice for men with prostate cancer? A qualitative study. BJU Int. 2002;90:257–64.CrossRefPubMed
24.
Pickles T, Ruether D, Weir L, Carlson L, Jakulj F, SCRN Communication Team. Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance. BJU Int. 2007;100:544–51.CrossRefPubMed
25.
Rossen S, Hansen-Nord NS, Kayser L, Borre M, Larsen RG, Trichopoulou A, et al. The impact of husbands’ prostate cancer diagnosis and participation in a behavioral lifestyle intervention on spouses’ lives and relationships with their partners. Cancer Nurs. 2015. doi:10.​1097/​NCC.​0000000000000259​.
26.
Victorson D, Hankin V, Burns J, Weiland R, Maletich C, Sufrin N, et al. Feasibility, acceptability and preliminary psychological benefits of mindfulness meditation training in a sample of men diagnosed with prostate cancer on active surveillance: results from a randomized controlled pilot trial. Psychooncology. 2016. doi:10.​1002/​pon.​4135.PubMed
27.
Kronenwetter C, Weidner G, Pettengill E, Marlin R, Crutchfield L, McCormac P, et al. A qualitative analysis of interviews of men with early stage prostate cancer: the Prostate Cancer Lifestyle Trial. Cancer Nurs. 2005;28:99–107.CrossRefPubMed
28.
Hawes SM, Malcarne VL, Ko CM, Sadler GR, Banthia R, Sherman SA, et al. Identifying problems faced by spouses and partners of patients with prostate cancer. Oncol Nurs Forum. 2006;33:807–14.CrossRefPubMed
29.
Voerman B, Visser A, Fischer M, Garssen B, VanAndel G, Bensing J. Determinants of participation in social support groups for prostate cancer patients. Psychooncology. 2007;16:1092–9.CrossRefPubMed
30.
Maliski SL, Heilemann MV, McCorkle R. From “death sentence” to “good cancer”: couples’ transformation of a prostate cancer diagnosis. Nurs Res. 2002;51:391–7.CrossRefPubMed
31.
Bottorff JL, Oliffe JL, Halpin M, Phillips M, McLean G, Mroz L. Women and prostate cancer support groups: the gender connect? Soc Sci Med. 2008;66:1217–27.CrossRefPubMed
32.
Traeger L, Penedo FJ, Gonzalez JS, Dahn JR, Lechner SC, Schneiderman N, et al. Illness perceptions and emotional well-being in men treated for localized prostate cancer. J Psychosom Res. 2009;67:389–97.CrossRefPubMed
33.
Underwood W, Orom H, Poch M, West BT, Lantz PM, Chang SS, et al. Multiple physician recommendations for prostate cancer treatment: a Pandora’s box for patients? Can J Urol. 2010;17:5346–54.PubMed
Metadata
Title
Qualitative insights into how men with low-risk prostate cancer choosing active surveillance negotiate stress and uncertainty
Authors
Emily M. Mader
Hsin H. Li
Kathleen D. Lyons
Christopher P. Morley
Margaret K. Formica
Scott D. Perrapato
Brian H. Irwin
John D. Seigne
Elias S. Hyams
Terry Mosher
Mark T. Hegel
Telisa M. Stewart
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Urology / Issue 1/2017
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-017-0225-3

Other articles of this Issue 1/2017

BMC Urology 1/2017 Go to the issue

Case report

Infrarenal high intra-abdominal testis: fusion of T2-weighted and diffusion-weighted magnetic resonance images and pathological findings

Research article

Management of large renal stones: laparoscopic pyelolithotomy versus percutaneous nephrolithotomy

Research article

Can Randall’s plug composed of calcium oxalate form via the free particle mechanism?

Research article

Comparison of radiofrequency ablation and partial nephrectomy for tumor in a solitary kidney

Research article

Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma

Research article

Lymphoepithelioma-like, a variant of urothelial carcinoma of the urinary bladder: a case report and systematic review for optimal treatment modality for disease-free survival